Carlos Perez-Ruiz, MD
Pain Medicine · Louisville, KYNPI 1659688208
Payments from drug & device makers
What this record shows
Abbott accounts for 61.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $4,313 and has fallen 83.0% since, to $733 in 2025.
Across 78 payments — averaging $85.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$715
- Nevro Corp.$295
- Globus Medical$282
- Avanos Medical$245
- Averitas Pharma Inc.$238
- plus $819 from 16 others
What the payments were for
- Travel & lodging$3,27149%
- Food & beverage$3,38451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $4,061 |
| Medtronic | 10 | $715 |
| Nevro Corp. | 7 | $295 |
| Globus Medical | 4 | $282 |
| Avanos Medical | 4 | $245 |
| Averitas Pharma Inc. | 2 | $238 |
| Boston Scientific | 3 | $207 |
| Vertex | 1 | $100 |
| Scilex Pharmaceuticals Inc. | 3 | $64 |
| GE HealthCare | 2 | $55 |
| Si-bone, Inc. | 2 | $51 |
| Stimwave Technologies Incorporated | 1 | $45 |
| SPR Therapeutics, Inc | 1 | $43 |
| AbbVie | 2 | $42 |
| Biotronik NRO, Inc. | 2 | $38 |
| Tonix Medicines, Inc. | 1 | $34 |
| Johnson & Johnson | 2 | $32 |
| Octapharma USA, Inc. | 1 | $31 |
| Edwards Lifesciences | 1 | $30 |
| Amgen | 1 | $19 |
| Merck | 1 | $17 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,654 in reported general payments places this provider in the 65th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 551 | $15,133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 552 | $10,868 |
| Lidocaine | 67 | $7,433 |
| Gabapentin | 539 | $6,883 |
| Pregabalin | 143 | $4,100 |
| Celecoxib | 132 | $2,451 |
| AmantadineAmantadine Hcl | 15 | $2,108 |
| Meloxicam | 82 | $2,100 |
| Tizanidine Hcl | 220 | $1,582 |
| Duloxetine Hcl | 90 | $1,116 |
| Oxycodone Hcl | 33 | $538 |
| Naloxone Hcl | 12 | $493 |
| Cyclobenzaprine Hcl | 61 | $466 |
| Tramadol Hcl | 107 | $463 |
| Amitriptyline Hcl | 65 | $392 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Louisville
- Timothy BeachamLouisville$31K
- James JacksonLouisville$14K
- Lawrence PetersLouisville$13K
- Stephen YoungLouisville$12K
- Michael CronenLouisville$10K
- Darel BarnettLouisville$9K
- Anilkumar VinayakanLouisville$7K
- Jason LewisLouisville$6K
- Brooke BauerLouisville$5K
- Dominique RazeeqLouisville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.